160 related articles for article (PubMed ID: 12851475)
21. Proteasome function is required for DNA damage response and fanconi anemia pathway activation.
Jacquemont C; Taniguchi T
Cancer Res; 2007 Aug; 67(15):7395-405. PubMed ID: 17671210
[TBL] [Abstract][Full Text] [Related]
22. The FA/BRCA pathway is involved in melphalan-induced DNA interstrand cross-link repair and accounts for melphalan resistance in multiple myeloma cells.
Chen Q; Van der Sluis PC; Boulware D; Hazlehurst LA; Dalton WS
Blood; 2005 Jul; 106(2):698-705. PubMed ID: 15802532
[TBL] [Abstract][Full Text] [Related]
23. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway.
Garcia-Higuera I; Taniguchi T; Ganesan S; Meyn MS; Timmers C; Hejna J; Grompe M; D'Andrea AD
Mol Cell; 2001 Feb; 7(2):249-62. PubMed ID: 11239454
[TBL] [Abstract][Full Text] [Related]
24. The interplay of Fanconi anemia proteins in the DNA damage response.
Wang X; D'Andrea AD
DNA Repair (Amst); 2004; 3(8-9):1063-9. PubMed ID: 15279794
[TBL] [Abstract][Full Text] [Related]
25. Bi-allelic silencing of the Fanconi anaemia gene FANCF in acute myeloid leukaemia.
Tischkowitz M; Ameziane N; Waisfisz Q; De Winter JP; Harris R; Taniguchi T; D'Andrea A; Hodgson SV; Mathew CG; Joenje H
Br J Haematol; 2003 Nov; 123(3):469-71. PubMed ID: 14617007
[TBL] [Abstract][Full Text] [Related]
26. The Fanconi anaemia/BRCA pathway.
D'Andrea AD; Grompe M
Nat Rev Cancer; 2003 Jan; 3(1):23-34. PubMed ID: 12509764
[TBL] [Abstract][Full Text] [Related]
27. Arsenic exposure disrupts the normal function of the FA/BRCA repair pathway.
Peremartí J; Ramos F; Marcos R; Hernández A
Toxicol Sci; 2014 Nov; 142(1):93-104. PubMed ID: 25092648
[TBL] [Abstract][Full Text] [Related]
28. Chemosensitizing tumor cells by targeting the Fanconi anemia pathway with an adenovirus overexpressing dominant-negative FANCA.
Ferrer M; de Winter JP; Mastenbroek DC; Curiel DT; Gerritsen WR; Giaccone G; Kruyt FA
Cancer Gene Ther; 2004 Aug; 11(8):539-46. PubMed ID: 15192709
[TBL] [Abstract][Full Text] [Related]
29. Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatin.
Jacquemont C; Simon JA; D'Andrea AD; Taniguchi T
Mol Cancer; 2012 Apr; 11():26. PubMed ID: 22537224
[TBL] [Abstract][Full Text] [Related]
30. New roads to FA/BRCA pathway: H2AX.
Lyakhovich A; Surrallés J
Cell Cycle; 2007 May; 6(9):1019-23. PubMed ID: 17471025
[TBL] [Abstract][Full Text] [Related]
31. New advances in the DNA damage response network of Fanconi anemia and BRCA proteins. FAAP95 replaces BRCA2 as the true FANCB protein.
Fei P; Yin J; Wang W
Cell Cycle; 2005 Jan; 4(1):80-6. PubMed ID: 15611632
[TBL] [Abstract][Full Text] [Related]
32. FANCE: the link between Fanconi anaemia complex assembly and activity.
Pace P; Johnson M; Tan WM; Mosedale G; Sng C; Hoatlin M; de Winter J; Joenje H; Gergely F; Patel KJ
EMBO J; 2002 Jul; 21(13):3414-23. PubMed ID: 12093742
[TBL] [Abstract][Full Text] [Related]
33. [The role of the Fanconi anemia pathway in the pathophysiology of ovarian cancer].
Synowiec A; Szenajch J; Wcisło G; Szczylik C
Ginekol Pol; 2015 Feb; 86(2):150-4. PubMed ID: 25807841
[TBL] [Abstract][Full Text] [Related]
34. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins.
Wang W
Nat Rev Genet; 2007 Oct; 8(10):735-48. PubMed ID: 17768402
[TBL] [Abstract][Full Text] [Related]
35. Functional defects in the fanconi anemia pathway in pancreatic cancer cells.
van der Heijden MS; Brody JR; Gallmeier E; Cunningham SC; Dezentje DA; Shen D; Hruban RH; Kern SE
Am J Pathol; 2004 Aug; 165(2):651-7. PubMed ID: 15277238
[TBL] [Abstract][Full Text] [Related]
36. The FANC/BRCA Pathway Releases Replication Blockades by Eliminating DNA Interstrand Cross-Links.
Renaudin X; Rosselli F
Genes (Basel); 2020 May; 11(5):. PubMed ID: 32466131
[TBL] [Abstract][Full Text] [Related]
37. Disruption of the FA/BRCA pathway in bladder cancer.
Neveling K; Kalb R; Florl AR; Herterich S; Friedl R; Hoehn H; Hader C; Hartmann FH; Nanda I; Steinlein C; Schmid M; Tonnies H; Hurst CD; Knowles MA; Hanenberg H; Schulz WA; Schindler D
Cytogenet Genome Res; 2007; 118(2-4):166-76. PubMed ID: 18000367
[TBL] [Abstract][Full Text] [Related]
38. Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway.
Chirnomas D; Taniguchi T; de la Vega M; Vaidya AP; Vasserman M; Hartman AR; Kennedy R; Foster R; Mahoney J; Seiden MV; D'Andrea AD
Mol Cancer Ther; 2006 Apr; 5(4):952-61. PubMed ID: 16648566
[TBL] [Abstract][Full Text] [Related]
39. Crosstalk between the nucleotide excision repair and Fanconi anemia/BRCA pathways.
Mouw KW; D'Andrea AD
DNA Repair (Amst); 2014 Jul; 19():130-4. PubMed ID: 24768451
[TBL] [Abstract][Full Text] [Related]
40. siRNA depletion of BRCA1, but not BRCA2, causes increased genome instability in Fanconi anemia cells.
Bruun D; Folias A; Akkari Y; Cox Y; Olson S; Moses R
DNA Repair (Amst); 2003 Sep; 2(9):1007-13. PubMed ID: 12967657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]